The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Identifying disparities in gynecologic cancer: Results and analysis from a patient preference survey.
 
Eloise Chapman-Davis
No Relationships to Disclose
 
Kimberly J. Halla
Consulting or Advisory Role - GlaxoSmithKline; Merck; Seagen
 
Shannon Neville Westin
Consulting or Advisory Role - Agenus; AstraZeneca; BioAscent; Clovis Oncology; Curio Science; Curio Science; Eisai; EQRX; Genentech; Gerson Lehrman Group; GlaxoSmithKline; Immunogen; Lilly; Medscape; Merck; Mereo BioPharma; Mersana; OncLive; Roche; Targeted Oncology; Vaniam Group; Vincerx Pharma; Zentalis
Research Funding - AstraZeneca (Inst); Bayer (Inst); Bio-Path Holdings, Inc (Inst); Clovis Oncology (Inst); Cotinga Pharmaceuticals (Inst); GlaxoSmithKline (Inst); GOG Foundation (Inst); Mereo BioPharma (Inst); Novartis (Inst); OncXerna Therapeutics (Inst); Roche/Genentech (Inst)
 
Ritu Salani
Consulting or Advisory Role - Arcus Biosciences; Clovis Oncology; Genentech; GlaxoSmithKline/Tesaro; Instil Bio; Merck; Regeneron; Seagen
Speakers' Bureau - Merck
 
Jerfiz D. Constanzo
No Relationships to Disclose
 
Timothy A. Quill
No Relationships to Disclose
 
Kathryn Burn
No Relationships to Disclose
 
Angeles Alvarez Secord
Honoraria - Myriad Genetics
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Clovis Oncology (Inst); Eisai (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Immutep (Inst); Merck (Inst); OncoQuest Pharmaceuticals (Inst); PharmaMar (Inst); Seagen (Inst); Tesaro (Inst); VBL Therapeutics (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline
(OPTIONAL) Uncompensated Relationships - Aravive; GOG Foundation; OncoQuest Pharmaceuticals; Regeneron; Roche/Genentech; VBL Therapeutics